HRT FINANCIAL LP

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1475597 NEW YORK, NY

Position in TAK

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$2,334,890

+$1,413,818 QoQ

Shares Held

126,074

+113.4% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $86,437,876 across 27 Drug Manufacturers - Specialty & Generic names. TAK ranks #8 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	66,842	$39,635,969
2	HLN	Haleon plc	1,100,190	$11,012,901
3	HIMS	Hims & Hers Health, Inc.	284,622	$5,908,752
4	TEVA	Teva Pharmaceutical Industries Ltd	140,222	$4,223,486
5	NBIX	Neurocrine Biosciences Inc	26,404	$3,478,462
6	LQDA	Liquidia Corp	86,687	$3,271,567
7	ALKS	Alkermes plc.	81,989	$2,899,131
8	TAK	Takeda Pharmaceutical Co Ltd This page	126,074	$2,334,890

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,334,890	126,074	+113.4%	Shares	Defined	2026-05-14
2025-12-31	$921,072	59,081	+29.2%	Shares	Defined	2026-02-12
2025-09-30	$669,516	45,732	+12.2%	Shares	Defined	2025-11-14
2025-06-30	$630,350	40,773	+86.1%	Shares	Defined	2025-08-14
2025-03-31	$325,771	21,908	-5.5%	Shares	Defined	2025-05-15
2024-03-31	$322,178	23,195	-61.1%	Shares	Defined	2024-05-13
2023-06-30	$936,740	59,627	+68.2%	Shares	Defined	2023-08-11
2023-03-31	$584,067	35,441	-55.0%	Shares	Defined	2023-05-12
2021-03-31	$1,439,381	78,827	+263.9%	Shares	Defined	2021-05-17
2020-09-30	$386,450	21,662	—	Shares	Defined	2020-11-13
No filing history on record for this holder in this stock.